GlassScriptPhysician profile
Hardie V Sorrels
NPI 1942314075
$572.19
in general payments reported to CMS, 2019-2025
12 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.17 · 2022: $23.32 · 2023: $117 · 2024: $132 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $252.47 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Glaxosmithkline, LLC. | $81.58 | 2023-2025 | Shingrix, Arexvy |
| Amgen INC. | $40.27 | 2023-2025 | Otezla, Repatha, Repatha |
| Inspire Medical Systems, INC. | $37.60 | 2025 | Inspire |
| Cequr Corporation | $31.45 | 2024 | Cequr Simplicity |
| Insulet Corporation | $24.28 | 2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $23.75 | 2025 | Airsupra |
| Xeris Pharmaceuticals, INC. | $18.19 | 2025 | Gvoke Hypopen |
| Amneal Pharmaceuticals LLC | $16.64 | 2025 | Unithroid |
| Sequel Med Tech, LLC | $16.43 | 2025 | Twiist |
| Lundbeck LLC | $15.67 | 2024 | Rexulti |
| Exact Sciences Corporation | $13.86 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hardie Sorrels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.